Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

NCT01270841 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hypogonadism

Interventions

DRUG: Placebo
DRUG: topical testosterone
DRUG: Androxal

Sponsor

Repros Therapeutics Inc.